ReviewJournal of medical case reports2025
Acquired hemophilia A: a case report and review of the literature.
Review in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Acquired Hemophilia A in Sjögren's Syndrome: An Uncommon Bleeding Disorder Masked by Antiplatelet Use.Annals of African medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcquired hemophilia A is a rare autoimmune disease characterized by inhibitory antibodies against coagulation factor VIII, leading to an increased risk of bleeding. The relevance of this case lies in its high associated morbidity and mortality, and the importance of early diagnosis in both medical and dental practice. CASE PRESENTATION: We present the clinical case of a 74-year-old Spanish Caucasian patient diagnosed with acquired hemophilia A. The patient was initially treated for progressive edema in the right lower limb, followed by hematomas in the tongue and submandibular region. The diagnosis was confirmed through hematological tests, which revealed a prolonged activated partial thromboplastin time and low coagulation factor VIII activity (2.4%). Treatment with hemostatic agents and corticosteroids was initiated, resulting in a favorable improvement of the hematomas.
conclusionsAcquired hemophilia A requires a multidisciplinary and personalized approach for each patient. Focus should be placed on prevention, early diagnosis, and appropriate treatment to effectively manage this coagulopathy and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.